Loading
ผศ.ดร. วันชนะ สืบไวย

ผศ.ดร. วันชนะ สืบไวย

ภาควิชานิติเวชศาสตร์,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
16481034400: H-INDEX 18

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Seubwai, W.
Wongkham, C.
Puapairoj, A.
Khuntikeo, N.
Wongkham, S.
2007
2. Vitamin D suppresses tumour growth and enhances cyto-toxicity of chemotherapeutic agents in cholangiocarcinoma S. Woncikham
W. Seubwail
C. Wongkham
A. Puapairoj
S. Okada
2008
3. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Seubwai, W
Wongkham, C
Puapairoj, A
Okada, S
Wongkham, S
2010
4. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinoma Wunchana Seubwai
Chaisiri Wongkham
Anucha Puapairoj
Seiji Okada
Sopit Wongkham
2010
5. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB Seubwai, W
Vaeteewoottacharn, K
Hiyoshi, M
Suzu, S
Puapairoj, A
Wongkham, C
Okada, S
Wongkham, S
2010
6. CEPHARANTHINE EXERTS ANTITUMOR ACTIVITY ON CHOLANGIOCARCINOMA BY INHIBITION OF NF-KB ACTION W. Seubwai
K. Vaeteewoottacharn
A. Puapairoj
C. Wongkham
S. Okada
S. Wongkham
2011
7. Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Uthaisar, K.
Seubwai, W.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Okada, S.
Wongkham, S.
2012
8. Hypoxia Enhances Aggressiveness of Cholangiocarcinoma Cells Seubwai, W.
Kraiklang, R.
Wongkham, C.
Wongkham, S.
2012
9. Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin Chariya Hahnvajanawong
Supaluk Ketnimit
Kovit Pattanapanyasat
Natthinee Anantachoke
Banchob Sripa
Khosit Pinmai
Wunchana Seubwai
Vichai Reutrakul
2012
10. Natural Products for Prevention and Treatment of Cholangiocarcinoma Chariya Hahnvajanawong
Khon Kaen University - Natural Products Chemistry Research Unit
Wunchana Seubwai
Faculty of Medicine - Department of Forensic Medicine
Thidarut Boonmars
Faculty of Medicine - Department of Parasitology
Kulthida Vaeteewoottacharn
Faculty of Medicine - Department of Biochemistry
2012
11. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Hahnvajanawong, C
Chaiyagool, J
Seubwai, W
Bhudhisawasdi, V
Namwat, N
Khuntikeo, N
Sripa, B
Pugkhem, A
Tassaneeyakul, W
2012
12. TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro Kidoikhammouan, S
Seubwai, W
Tantapotinan, N
Silsirivanit, A
Wongkham, S
Sawanyawisuth, K
Wongkham, C
2012
13. Determining the Manner of Death Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study Wunchana Seubwai
Wirut Khunkitti
Maneewan Tanratanavijit
Thitichai Wiangsimma
Molin Wongwattanakul
Patcharee Jearanaikoon
Sirinart Srichan
2013
14. Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters Wunchana Seubwai
Kulthida Vaeteewoottacharn
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2013
15. Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs Puthdee, N
Vaeteewoottacharn, K
Seubwai, W
Wonkchalee, O
Kaewkong, W
Juasook, A
Pinlaor, S
Pairojkul, C
Wongkham, C
Okada, S
Boonmars, T
Wongkham, S
2013
16. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. Wunchana Seubwai
Chaisiri Wongkham
Anucha Puapairoj
Narong Khuntikeo
Ake Pugkhem
Chariya Hahnvajanawong
Jariya Chaiyagool
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2014
17. A NOVEL ANTICANCER ALKALOID TILIACORININE INDUCES SUSTAINED ACTIVATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE AND SYNERGIZES WITH CISPLATIN IN CHOLANGIOCARCINOMA CELLS S. Janeklang
W. Seubwai
K. Vaeteewoottacharn
P. Boonsiri
G. Kismali
A. Nakaew
A. Suksamrarn
S. Okada
S. Wongkham
2014
18. Application of Molecular Biology Techniques on Forensic Sciences Wunchana Seubwai
Wirut Khunkitti
2014
19. Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines Hematulin, A.
Sagan, D.L.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, S.
2014
20. Diabetogenic Glucose Enhances Aggressive Activities of Cholangiocarcinoma Cell Lines Charupong Saengboonmee
Wunchana Seubwai
Sopit Wongkham
2014
21. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014
22. In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma Somkid Janeklang
Archawin Nakaew
Kulthida Vaeteewoottacharn
Wunchana Seubwai
Patcharee Boonsiri
Gorkem Kismali
Apichart Suksamrarn
Seiji Okada
Sopit Wongkham
2014
23. Potential Glyco-Biomarkers Identified Suicide Victims Wunchana Seubwai
Wirut Khunkitti
Maneewan Tanratanavijit
Thitichai Wiangsimma
Sopit Wongkham
2014
24. Potential targeted therapy for liver fluke associated cholangiocarcinoma. Vaeteewoottacharn, K.
Seubwai, W.
Bhudhisawasdi, V.
Okada, S.
Wongkham, S.
2014
25. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. Saengboonmee, C.
Seubwai, W.
Wongkham, C.
Wongkham, S.
2015
26. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. Wareeporn Wattanawongdon
Chariya Hahnvajanawong
Nisana Namwat
Sirimas Kanchanawat
Thidarut Boonmars
Patcharee Jearanaikoon
Chanwit Leelayuwat
Anchalee Techasen
Wunchana Seubwai
2015
27. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach Pattanapairoj, S
Silsirivanit, A
Muisuk, K
Seubwai, W
Cha'on, U
Vaeteewoottacharn, K
Sawanyawisuth, K
Chetchotsak, D
Wongkham, S
2015
28. Inhibition of NF-kappa B Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells Wunchana Seubwai
Kulthida Vaeteewoottacharn
Ratthaphol Kraiklang
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2015
29. Synthesis of 5-fluorouracil nanoparticles and its inhibition of Cholangiocarcinoma in vitro N. Ngernyuang
W. Seubwai
S. Daduang
P. Boonsiri
T. Limpaiboon
J. Daduang
2015
30. Tumor Glycolysis as a Target for Cancer Diagnosis and Therapy Wunchana Seubwai 2015
31. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity Uthaisar, K
Vaeteewoottacharn, K
Seubwai, W
Talabnin, C
Sawanyawisuth, K
Obchoei, S
Kraiklang, R
Okada, S
Wongkham, S
2016
32. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. Saengboonmee, C.
Seubwai, W.
Pairojkul, C.
Wongkham, S.
2016
33. Inhibition of NF-κB activity enhances sensitivity to anticancer drugs in cholangiocarcinoma cells Seubwai, W
Vaeteewoottacharn, K
Kraiklang, R
Umezawa, K
Okada, S
Wongkham, S
2016
34. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB Chatchai Phoomak
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Chaisiri Wongkham
Atit Silsirivanit
Sopit Wongkham
2016
35. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. Thonsri, U
Seubwai, W
Waraasawapati, S
Sawanyawisuth, K
Vaeteewoottacharn, K
Boonmars, T
Cha'on, U
2016
36. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent Ngernyuang, N.
Seubwai, W.
Daduang, S.
Boonsiri, P.
Limpaiboon, T.
Daduang, J.
2016
37. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways. Puthdee, N.
Seubwai, W.
Vaeteewoottacharn, K.
Boonmars, T.
Cha'on, U.
Phoomak, C.
2017
38. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation Phoomak, C
Vaeteewoottacharn, K
Silsirivanit, A
Saengboonmee, C
Seubwai, W
Sawanyawisuth, K
Wongkham, C
Wongkham, S
2017
39. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. Saengboonmee, C
Seubwai, W
Cha'on, U
Sawanyawisuth, K
Wongkham, S
Wongkham, C
2017
40. Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB Charupong Saengboonmee
Wunchana Seubwai
Ubon Cha'on
Kanlayanee Sawanyawisuth
Sopit Wongkham
Chaisiri Wongkham
2017
41. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis Unchalee Thonsri
Wunchana Seubwai
Sakda Waraasawapati
Kanlayanee Sawanyawisuth
Kulthida Vaeteewoottacharn
Thidarat Boonmars
Ubon Cha'on
2017
42. Targeting hexokinase II as a possible therapy for cholangiocarcinoma Ubonrat Thamrongwaranggoon
Wunchana Seubwai
Chatchai Phoomak
Sakkarn Sangkhamanon
Ubon Cha'on
Thidarat Boonmars
Sopit Wongkham
2017
43. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. Paweena Dana
Ryusho Kariya
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Kouki Matsuda
Seiji Okada
Sopit Wongkham
2017
44. Activation of vimentin is critical to promote a metastatic potential of cholangiocarcinoma cells Waraporn Saentaweesuk
Norie Araki
Kulthida Vaeteewoottacharn
Atit Silsirivanit
Wunchana Seubwai
Chutima Talabnin
Kanha Muisuk
Banchob Sripa
Sopit Wongkham
Seiji Okada
Chaisiri Wongkham
2018
45. ANTI-MALARIAL DRUGS ARTESUNATE AND CHLOROQUINE INDUCE CELL DEATH BY DIFFERENT MECHANISMS IN BILE DUCT CANCER CELL LINES Diwakar Guragain
Norie Araki
Atit Silsinivanit
Wunchana Seubwai
Ubon Cha'on
2018
46. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms Diwakar Guragain
Wunchana Seubwai
Daiki Kobayashi
Atit Silsinivanit
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
Sopit Wongkham
Norie Araki
Ubon Cha'on
2018
47. Chloroquine reduces metastases of cholangiocarcinoma cells in lungs by tail vein assay of cancer metastasis Kanokwan Nahok
Diwakar Guragain
Sopit Wongkham
Wunchana Seubwai
Ubon Cha'on
2018
48. Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy Molin Wongwattanakul
Chariya Hahnvajanawong
Wunchana Seubwai
Chanvit Leelayuwat
Temduang Limpaiboon
Patcharee Jearanaikoon
2018
49. Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma. Sonexai Kidoikhammouan
Wunchana Seubwai
Atit Silsirivanit
Sopit Wongkham
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
2019
50. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients Silsirivanit, A
Phoomak, C
Teeravirote, K
Wattanavises, S
Seubwai, W
Saengboonmee, C
Zhan, Z
Inokuchi, JI
Suzuki, A
Wongkham, S
2019
51. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. Surangkana Sanmai
Tanakorn Proungvitaya
Temduang Limpaiboon
Daraporn Chua-On
Wunchana Seubwai
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019
52. Antitumor effect of Shikonin, a PKM2 inhibitor, in Cholangiocarcinoma cell lines Unchalee Thonsri
Wunchana Seubwai
Sakda Waraasawapati
Sopit Wongkham
Thidarat Boonmars
Ubon Cha'on
Chaisiri Wongkham
2020
53. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Banchob Sripa
Wunchana Seubwai
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Worasak Kaewkong
Kanha Muisuk
Paweena Dana
Chatchai Phoomak
Worachart Lert-itthiporn
Vor Luvira
Chawalit Pairojkul
Bin T. Teh
Sopit Wongkham
Seiji Okada
Yaovalux Chamgramol
2020
54. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma. Atit Silsirivanit
Atsushi Matsuda
Atsushi Kuno
Chikayuki Tsuruno
Yuta Uenoyama
Wunchana Seubwai
Kiyohiko Angata
Karuntarat Teeravirote
Chaisiri Wongkham
Norie Araki
Youichi Takahama
Sopit Wongkham
Hisashi Narimatsu
2020
55. NF-kappa B and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells Saengboonmee, C
Phoomak, C
Supabphol, S
Covington, KR
Hampton, O
Wongkham, C
Gibbs, RA
Umezawa, K
Seubwai, W
Gingras, MC
Wongkham, S
2020
56. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. Seubwai, W.
Cha'on, U.
Wongkham, S.
2021
57. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. Charupong Saengboonmee
Wunchana Seubwai
Worachart Lert-Itthiporn
Thanachai Sanlung
Sopit Wongkham
2021
58. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma Prin Sungwan
Worachart Lert-itthiporn
Atit Silsirivanit
Nathakan Klinhom-on
Seiji Okada
Sopit Wongkham
Wunchana Seubwai
2021
59. Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus Charupong Saengboonmee
Wunchana Seubwai
Sakkarn Sangkhamanon
Marutpong Detarya
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Sopit Wongkham
2021
60. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients Klinhom-On, N
Seubwai, W
Sawanyawisuth, K
Lert-Itthiporn, W
Waraasawapati, S
Detarya, M
Wongkham, S
2021
61. High glucose: an emerging association between diabetes mellitus and cancer progression Supabphol, S
Seubwai, W
Wongkham, S
Saengboonmee, C
2021
62. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus Saengboonmee, C
Detarya, M
Sangkhamanon, S
Sawanyawisuth, K
Seubwai, W
Wongkham, S
2021
63. High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 Unchalee Thonsri
Sopit Wongkham
Chaisiri Wongkham
Shinjiro Hino
Mitsuyoshi Nakao
Sittiruk Roytrakul
Tomoaki Koga
Wunchana Seubwai
2021
64. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Seubwai, W.
Phoomak, C.
Saengboonmee, C.
Wongkham, S.
Wongkham, C.
2021
65. Kallikrein-11, in association with coiled-coil domain containing 25, as a potential prognostic marker for cholangiocarcinoma with lymph node metastasis Saeranee Siriphak
Ravinnipa Chanakankun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Doungdean Tummanatsakun
Wunchana Seubwai
Molin Wongwattanakul
Siriporn Proungvitaya
2021
Count 47 44 52 7

Title Authors Year Publication name Cited count
< 2016 2017 2018 2019 2020 2021 รวม
1. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: Implications for therapeutics Seubwai, W.
Wongkham, C.
Puapairoj, A.
Khuntikeo, N.
Wongkham, S.
2007 Cancer
12 (109), pp. 2497-2505
2. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinoma Seubwai, W.
Wongkham, C.
Puapairoj, A.
Okada, S.
Wongkham, S.
2010 Cancer
23 (116), pp. 5535-5543
3. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB Seubwai, W.
Vaeteewoottacharn, K.
Puapairoj, A.
Okada, S.
Wongkham, S.
2010 Cancer Science
7 (101), pp. 1590-1595
4. Cepharanthine Suppresses Metastatic Potential of Human Cholangiocarcinoma Cell Lines Uthaisar, K.
Seubwai, W.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Okada, S.
Wongkham, S.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 149-154
5. Hypoxia enhances aggressiveness of Cholangiocarcinoma cells Seubwai, W.
Kraiklang, R.
Wongkham, C.
Wongkham, S.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 53-58
6. Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin Hahnvajanawong, C.
Ketnimit, S.
Anantachoke, N.
Sripa, B.
Pinmai, K.
Seubwai, W.
Reutrakul, V.
2012 Biological and Pharmaceutical Bulletin
11 (35), pp. 1914-1925
7. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Hahnvajanawong, C.
Chaiyagool, J.
Seubwai, W.
Bhudhisawasdi, V.
Namwat, N.
Khuntikeo, N.
Sripa, B.
Pugkhem, A.
Tassaneeyakul, W.
2012 World Journal of Gastroenterology
30 (18), pp. 3955-3961
8. TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro Kidoikhammouan, S.
Seubwai, W.
Tantapotinan, N.
Silsirivanit, A.
Wongkham, S.
Sawanyawisuth, K.
Wongkham, C.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 155-160
9. Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs Puthdee, N.
Vaeteewoottacharn, K.
Seubwai, W.
Wonkchalee, O.
Kaewkong, W.
Juasook, A.
Pinlaor, S.
Pairojkul, C.
Wongkham, C.
Okada, S.
Boonmars, T.
Wongkham, S.
2013 Korean Journal of Parasitology
6 (51), pp. 711-717
10. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: Implications for targeted therapy Seubwai, W.
Wongkham, C.
Puapairoj, A.
Khuntikeo, N.
Pugkhem, A.
Hahnvajanawong, C.
Chaiyagool, J.
Umezawa, K.
Okada, S.
Wongkham, S.
2014 PLoS ONE
8 (9), pp.
11. Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines Hematulin, A.
Sagan, D.L.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, S.
2014 International Journal of Oncology
3 (45), pp. 1159-1166
12. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014 Asian Pacific Journal of Cancer Prevention
14 (15), pp. 5873-5878
13. In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma Janeklang, S.
Nakaew, A.
Vaeteewoottacharn, K.
Seubwai, W.
Boonsiri, P.
Kismali, G.
Suksamrarn, A.
Okada, S.
Wongkham, S.
2014 Asian Pacific Journal of Cancer Prevention
17 (15), pp. 7473-7478
14. Potential targeted therapy for liver fluke associated cholangiocarcinoma Vaeteewoottacharn, K.
Seubwai, W.
Bhudhisawasdi, V.
Okada, S.
Wongkham, S.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
6 (21), pp. 362-370
15. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma Saengboonmee, C.
Seubwai, W.
Wongkham, C.
Wongkham, S.
2015 Cancer Epidemiology
3 (39), pp. 274-278
16. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wattanawongdon, W.
Hahnvajanawong, C.
Namwat, N.
Kanchanawat, S.
Boonmars, T.
Jearanaikoon, P.
Leelayuwat, C.
Techasen, A.
Seubwai, W.
2015 International Journal of Oncology
1 (47), pp. 398-410
17. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach Pattanapairoj, S.
Silsirivanit, A.
Muisuk, K.
Seubwai, W.
Cha'on, U.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Chetchotsak, D.
Wongkham, S.
2015 Clinical Biochemistry
10-11 (48), pp. 668-673
18. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity Uthaisar, K.
Vaeteewoottacharn, K.
Seubwai, W.
Talabnin, C.
Sawanyawisuth, K.
Obchoei, S.
Kraiklang, R.
Okada, S.
Wongkham, S.
2016 Oncology Reports
3 (36), pp. 1435-1446
19. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation Saengboonmee, C.
Seubwai, W.
Pairojkul, C.
Wongkham, S.
2016 Scientific Reports
(6), pp.
20. Inhibition of NF-κB activity enhances sensitivity to anticancer drugs in cholangiocarcinoma cells Seubwai, W.
Vaeteewoottacharn, K.
Kraiklang, R.
Okada, S.
Wongkham, S.
2016 Oncology Research
1-2 (23), pp. 21-28
21. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB Phoomak, C.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, C.
Silsirivanit, A.
Wongkham, S.
2016 Scientific Reports
(6), pp.
22. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent Ngernyuang, N.
Seubwai, W.
Daduang, S.
Boonsiri, P.
Limpaiboon, T.
Daduang, J.
2016 Materials Science and Engineering C
(60), pp. 411-415
23. Berberine induces cell cycle arrest in cholangiocarcinoma cell lines via inhibition of NF-κB and STAT3 pathways Puthdee, N.
Seubwai, W.
Vaeteewoottacharn, K.
Boonmars, T.
Cha'on, U.
Phoomak, C.
2017 Biological and Pharmaceutical Bulletin
6 (40), pp. 751-757
24. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation Phoomak, C.
Vaeteewoottacharn, K.
Silsirivanit, A.
Saengboonmee, C.
Seubwai, W.
Sawanyawisuth, K.
Wongkham, C.
2017 Scientific Reports
(7), pp.
25. Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB Saengboonmee, C.
Seubwai, W.
Cha'on, U.
Sawanyawisuth, K.
Wongkham, C.
2017 Anticancer Research
1 (37), pp. 115-123
26. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis Seubwai, W.
Waraasawapati, S.
Sawanyawisuth, K.
Vaeteewoottacharn, K.
Chaon, U.
2017 Histology and Histopathology
5 (32), pp. 503-510
27. Targeting hexokinase II as a possible therapy for cholangiocarcinoma Seubwai, W.
Phoomak, C.
Cha'on, U.
Boonmars, T.
2017 Biochemical and Biophysical Research Communications
2 (484), pp. 409-415
28. Upregulation of CD147 promotes metastasis of cholangiocarcinoma by modulating the epithelial-to-mesenchymal transitional process Vaeteewoottacharn, K.
Sawanyawisuth, K.
Seubwai, W.
2017 Oncology Research
7 (25), pp. 1047-1059
29. Activation of vimentin is critical to promote a metastatic potential of cholangiocarcinoma cells Vaeteewoottacharn, K.
Silsirivanit, A.
Seubwai, W.
Talabnin, C.
Muisuk, K.
Sripa, B.
Wongkham, S.
Okada, S.
Wongkham, C.
2018 Oncology Research
4 (26), pp. 605-616
30. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms Seubwai, W.
Kobayashi, D.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Wongkham, C.
Wongkham, S.
2018 Cellular and Molecular Biology
10 (64), pp. 113-118
31. Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy Hahnvajanawong, C.
Seubwai, W.
Leelayuwat, C.
Limpaiboon, T.
Jearanaikoon, P.
2018 Journal of Molecular Structure
(1166), pp. 416-421
32. Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma Kidoikhammouan, S.
Seubwai, W.
Silsirivanit, A.
Wongkham, S.
Sawanyawisuth, K.
Wongkham, C.
2019 Journal of Cancer Research and Therapeutics
1 (15), pp. 148-152
33. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients Silsirivanit, A.
Phoomak, C.
Seubwai, W.
Saengboonmee, C.
Wongkham, S.
2019 Glycoconjugate Journal
(), pp.
34. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Seubwai, W.
Wongkham, S.
Wongkham, C.
Somintara, O.
Patrakitkomjorn, S.
2019 Oncology Letters
6 (17), pp. 5275-5282
35. Antitumor effect of Shikonin, a PKM2 inhibitor, in Cholangiocarcinoma cell lines Seubwai, W.
Waraasawapati, S.
Wongkham, S.
Cha'on, U.
Wongkham, C.
2020 Anticancer Research
9 (40), pp. 5115-5124
36. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient Sripa, B.
Seubwai, W.
Vaeteewoottacharn, K.
Sawanyawisuth, K.
Silsirivanit, A.
Kaewkong, W.
Muisuk, K.
Phoomak, C.
Lert-Itthiporn, W.
Pairojkul, C.
Wongkham, S.
Okada, S.
Chamgramol, Y.
2020 Human Cell
3 (33), pp. 695-708
37. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma Silsirivanit, A.
Seubwai, W.
Wongkham, C.
Wongkham, S.
2020 Clinica Chimica Acta
(510), pp. 142-149
38. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells Saengboonmee, C.
Phoomak, C.
Wongkham, C.
Seubwai, W.
Wongkham, S.
2020 Life Sciences
(262), pp.
39. Aberrant GLUT1 expression is associated with carcinogenesis and progression of liver fluke-associated cholangiocarcinoma Seubwai, W.
Cha'on, U.
Wongkham, S.
2021 In Vivo
1 (35), pp. 267-274
40. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication Saengboonmee, C.
Seubwai, W.
Lert-Itthiporn, W.
Wongkham, S.
2021 Canadian Journal of Diabetes
3 (45), pp. 282-290
41. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma Lert-Itthiporn, W.
Silsirivanit, A.
Okada, S.
Wongkham, S.
Seubwai, W.
2021 PeerJ
(9), pp.
42. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients Seubwai, W.
Sawanyawisuth, K.
Lert-Itthiporn, W.
Waraasawapati, S.
Wongkham, S.
2021 Heliyon
4 (7), pp.
43. High glucose: an emerging association between diabetes mellitus and cancer progression Seubwai, W.
Wongkham, S.
Saengboonmee, C.
2021 Journal of Molecular Medicine
9 (99), pp. 1175-1193
44. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus Saengboonmee, C.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, S.
2021 Nutrition and Cancer
(), pp.
45. High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 Wongkham, S.
Wongkham, C.
Seubwai, W.
2021 Cancer Science
1 (112), pp. 254-264
46. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Seubwai, W.
Phoomak, C.
Saengboonmee, C.
Wongkham, S.
Wongkham, C.
2021 Life Sciences
(271), pp.
47. Kallikrein-11, in association with coiled-coil domain containing 25, as a potential prognostic marker for cholangiocarcinoma with lymph node metastasis Chanakankun, R.
Proungvitaya, T.
Seubwai, W.
Wongwattanakul, M.
Patrakitkomjorn, S.
2021 Molecules
11 (26), pp.

Title Authors Year Journal title
1. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Seubwai, W
Wongkham, C
Puapairoj, A
Khuntikeo, N
Wongkham, S
2007 Cancer
12 (109), pp. 2497-505
2. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Seubwai, W
Wongkham, C
Puapairoj, A
Okada, S
Wongkham, S
2010 Cancer
23 (116), pp. 5535-43
3. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Seubwai, W
Vaeteewoottacharn, K
Hiyoshi, M
Suzu, S
Puapairoj, A
Wongkham, C
Okada, S
Wongkham, S
2010 Cancer science
7 (101), pp. 1590-5
4. Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Uthaisar, K
Seubwai, W
Srikoon, P
Vaeteewoottacharn, K
Sawanyawisuth, K
Okada, S
Wongkham, S
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 149-54
5. Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin. Hahnvajanawong, C
Ketnimit, S
Pattanapanyasat, K
Anantachoke, N
Sripa, B
Pinmai, K
Seubwai, W
Reutrakul, V
2012 Biological & pharmaceutical bulletin
11 (35), pp. 1914-25
6. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. Hahnvajanawong, C
Chaiyagool, J
Seubwai, W
Bhudhisawasdi, V
Namwat, N
Khuntikeo, N
Sripa, B
Pugkhem, A
Tassaneeyakul, W
2012 World journal of gastroenterology : WJG
30 (18), pp. 3955-61
7. Hypoxia enhances aggressiveness of cholangiocarcinoma cells. Seubwai, W
Kraiklang, R
Wongkham, C
Wongkham, S
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 53-8
8. TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro. Kidoikhammouan, S
Seubwai, W
Tantapotinan, N
Silsirivanit, A
Wongkham, S
Sawanyawisuth, K
Wongkham, C
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 155-60
9. Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs. Puthdee, N
Vaeteewoottacharn, K
Seubwai, W
Wonkchalee, O
Kaewkong, W
Juasook, A
Pinlaor, S
Pairojkul, C
Wongkham, C
Okada, S
Boonmars, T
Wongkham, S
2013 The Korean journal of parasitology
6 (51), pp. 711-7
10. Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. Seubwai, W
Wongkham, C
Puapairoj, A
Khuntikeo, N
Pugkhem, A
Hahnvajanawong, C
Chaiyagool, J
Umezawa, K
Okada, S
Wongkham, S
2014 PloS one
8 (9), pp. e106056
11. In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma. Janeklang, S
Nakaew, A
Vaeteewoottacharn, K
Seubwai, W
Boonsiri, P
Kismali, G
Suksamrarn, A
Okada, S
Wongkham, S
2014 Asian Pacific journal of cancer prevention : APJCP
17 (15), pp. 7473-8
12. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S
Yongvanit, P
Loilome, W
Seubwai, W
Phunicom, K
Tassaneeyakul, W
Pairojkul, C
Promkotra, W
Techasen, A
Namwat, N
2014 Asian Pacific journal of cancer prevention : APJCP
14 (15), pp. 5873-8
13. Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines. Hematulin, A
Sagan, D
Sawanyawisuth, K
Seubwai, W
Wongkham, S
2014 International journal of oncology
3 (45), pp. 1159-66
14. Potential targeted therapy for liver fluke associated cholangiocarcinoma. Vaeteewoottacharn, K
Seubwai, W
Bhudhisawasdi, V
Okada, S
Wongkham, S
2014 Journal of hepato-biliary-pancreatic sciences
6 (21), pp. 362-70
15. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. Wattanawongdon, W
Hahnvajanawong, C
Namwat, N
Kanchanawat, S
Boonmars, T
Jearanaikoon, P
Leelayuwat, C
Techasen, A
Seubwai, W
2015 International journal of oncology
1 (47), pp. 398-410
16. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. Saengboonmee, C
Seubwai, W
Wongkham, C
Wongkham, S
2015 Cancer epidemiology
3 (39), pp. 274-8
17. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. Pattanapairoj, S
Silsirivanit, A
Muisuk, K
Seubwai, W
Cha'on, U
Vaeteewoottacharn, K
Sawanyawisuth, K
Chetchotsak, D
Wongkham, S
2015 Clinical biochemistry
10 (48), pp. 668-73
18. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. Uthaisar, K
Vaeteewoottacharn, K
Seubwai, W
Talabnin, C
Sawanyawisuth, K
Obchoei, S
Kraiklang, R
Okada, S
Wongkham, S
2016 Oncology reports
3 (36), pp. 1435-46
19. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. Seubwai, W
Vaeteewoottacharn, K
Kraiklang, R
Umezawa, K
Okada, S
Wongkham, S
2016 Oncology research
1 (23), pp. 21-8
20. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. Thonsri, U
Seubwai, W
Waraasawapati, S
Sawanyawisuth, K
Vaeteewoottacharn, K
Boonmars, T
Cha'on, U
2016 Histology and histopathology
(), pp. 11819
21. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. Phoomak, C
Vaeteewoottacharn, K
Sawanyawisuth, K
Seubwai, W
Wongkham, C
Silsirivanit, A
Wongkham, S
2016 Scientific reports
(6), pp. 27853
22. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. Saengboonmee, C
Seubwai, W
Pairojkul, C
Wongkham, S
2016 Scientific reports
(6), pp. 18995
23. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent. Ngernyuang, N
Seubwai, W
Daduang, S
Boonsiri, P
Limpaiboon, T
Daduang, J
2016 Materials science & engineering. C, Materials for biological applications
(60), pp. 411-5
24. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. Dana, P
Kariya, R
Vaeteewoottacharn, K
Sawanyawisuth, K
Seubwai, W
Matsuda, K
Okada, S
Wongkham, S
2017 Oncology research
7 (25), pp. 1047-1059
25. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. Saengboonmee, C
Seubwai, W
Cha'on, U
Sawanyawisuth, K
Wongkham, S
Wongkham, C
2017 Anticancer research
1 (37), pp. 115-123
26. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Thamrongwaranggoon, U
Seubwai, W
Phoomak, C
Sangkhamanon, S
Cha'on, U
Boonmars, T
Wongkham, S
2017 Biochemical and biophysical research communications
2 (484), pp. 409-415
27. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. Phoomak, C
Vaeteewoottacharn, K
Silsirivanit, A
Saengboonmee, C
Seubwai, W
Sawanyawisuth, K
Wongkham, C
Wongkham, S
2017 Scientific reports
(7), pp. 43842
28. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways. Puthdee, N
Seubwai, W
Vaeteewoottacharn, K
Boonmars, T
Cha'on, U
Phoomak, C
Wongkham, S
2017 Biological & pharmaceutical bulletin
6 (40), pp. 751-757
29. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms. Guragain, D
Seubwai, W
Kobayashi, D
Silsinivanit, A
Vaeteewoottacharn, K
Sawanyawisuth, K
Wongkham, C
Wongkham, S
Araki, N
Cha'on, U
2018 Cellular and molecular biology (Noisy-le-Grand, France)
10 (64), pp. 113-118
30. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells. Saentaweesuk, W
Araki, N
Vaeteewoottacharn, K
Silsirivanit, A
Seubwai, W
Talabnin, C
Muisuk, K
Sripa, B
Wongkham, S
Okada, S
Wongkham, C
2018 Oncology research
4 (26), pp. 605-616
31. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. Sanmai, S
Proungvitaya, T
Limpaiboon, T
Chua-On, D
Seubwai, W
Roytrakul, S
Wongkham, S
Wongkham, C
Somintara, O
Sangkhamanon, S
Proungvitaya, S
2019 Oncology letters
6 (17), pp. 5275-5282
32. Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma. Kidoikhammouan, S
Seubwai, W
Silsirivanit, A
Wongkham, S
Sawanyawisuth, K
Wongkham, C
2019 Journal of cancer research and therapeutics
1 (15), pp. 148-152
33. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients. Silsirivanit, A
Phoomak, C
Teeravirote, K
Wattanavises, S
Seubwai, W
Saengboonmee, C
Zhan, Z
Inokuchi, JI
Suzuki, A
Wongkham, S
2019 Glycoconjugate journal
2 (36), pp. 103-111
34. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma. Silsirivanit, A
Matsuda, A
Kuno, A
Tsuruno, C
Uenoyama, Y
Seubwai, W
Angata, K
Teeravirote, K
Wongkham, C
Araki, N
Takahama, Y
Wongkham, S
Narimatsu, H
2020 Clinica chimica acta; international journal of clinical chemistry
(510), pp. 142-149
35. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Sripa, B
Seubwai, W
Vaeteewoottacharn, K
Sawanyawisuth, K
Silsirivanit, A
Kaewkong, W
Muisuk, K
Dana, P
Phoomak, C
Lert-Itthiporn, W
Luvira, V
Pairojkul, C
Teh, BT
Wongkham, S
Okada, S
Chamgramol, Y
2020 Human cell
3 (33), pp. 695-708
36. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells. Saengboonmee, C
Phoomak, C
Supabphol, S
Covington, KR
Hampton, O
Wongkham, C
Gibbs, RA
Umezawa, K
Seubwai, W
Gingras, MC
Wongkham, S
2020 Life sciences
(262), pp. 118548
37. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines. Thonsri, U
Seubwai, W
Waraasawapati, S
Wongkham, S
Boonmars, T
Cha'on, U
Wongkham, C
2020 Anticancer research
9 (40), pp. 5115-5124
38. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. Saengboonmee, C
Seubwai, W
Lert-Itthiporn, W
Sanlung, T
Wongkham, S
2021 Canadian journal of diabetes
3 (45), pp. 282-290
39. High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8. Thonsri, U
Wongkham, S
Wongkham, C
Hino, S
Nakao, M
Roytrakul, S
Koga, T
Seubwai, W
2021 Cancer science
1 (112), pp. 254-264
40. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. Thamrongwaranggoon, U
Sangkhamanon, S
Seubwai, W
Saranaruk, P
Cha'on, U
Wongkham, S
2021 In vivo (Athens, Greece)
1 (35), pp. 267-274
41. High glucose: an emerging association between diabetes mellitus and cancer progression. Supabphol, S
Seubwai, W
Wongkham, S
Saengboonmee, C
2021 Journal of molecular medicine (Berlin, Germany)
9 (99), pp. 1175-1193
42. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. Saengboonmee, C
Detarya, M
Sangkhamanon, S
Sawanyawisuth, K
Seubwai, W
Wongkham, S
2021 Nutrition and cancer
(), pp. 1-11
43. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. Klinhom-On, N
Seubwai, W
Sawanyawisuth, K
Lert-Itthiporn, W
Waraasawapati, S
Detarya, M
Wongkham, S
2021 Heliyon
4 (7), pp. e06846
44. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. Sungwan, P
Lert-Itthiporn, W
Silsirivanit, A
Klinhom-On, N
Okada, S
Wongkham, S
Seubwai, W
2021 PeerJ
(9), pp. e11067

Title Authors Year Journal title Cited count
< 2016 2017 2018 2019 2020 2021 รวม
1. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma - Implications for therapeutics Wunchana Seubwai
Chaisiri Wongkham
Anucha Puapairoj
Narong Khuntikeo
Sopit Wongkham
2007 CANCER
12.0 (109.0), pp. 2497.0-2505.0
52 0 0 0 0 0 52
2. Vitamin D suppresses tumour growth and enhances cyto-toxicity of chemotherapeutic agents in cholangiocarcinoma S. Woncikham
W. Seubwail
C. Wongkham
A. Puapairoj
S. Okada
2008 EJC SUPPLEMENTS
9.0 (6.0), pp. 154.0-154.0
0 0 0 0 0 0 0
3. 22-Oxa-1,25-Dihydroxyvitamin D-3 Efficiently Inhibits Tumor Growth in Inoculated Mice and Primary Histoculutre of Cholangiocarcinoma Wunchana Seubwai
Chaisiri Wongkham
Anucha Puapairoj
Seiji Okada
Sopit Wongkham
2010 CANCER
23.0 (116.0), pp. 5535.0-5543.0
23 0 0 0 0 0 23
4. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappa B Wunchana Seubwai
Kulthida Vaeteewoottacharn
Masateru Hiyoshi
Shinya Suzu
Anucha Puapairoj
Chairisi Wongkham
Seiji Okada
Sopit Wongkham
2010 CANCER SCIENCE
7.0 (101.0), pp. 1590.0-1595.0
59 0 0 0 0 0 59
5. CEPHARANTHINE EXERTS ANTITUMOR ACTIVITY ON CHOLANGIOCARCINOMA BY INHIBITION OF NF-KB ACTION W. Seubwai
K. Vaeteewoottacharn
A. Puapairoj
C. Wongkham
S. Okada
S. Wongkham
2011 JOURNAL OF HEPATOLOGY
(54.0), pp. S59-S59
0 0 0 0 0 0 0
6. Cepharanthine Suppresses Metastatic Potential of Human Cholangiocarcinoma Cell Lines Kwuntida Uthaisar
Wunchana Seubwai
Pattravedee Srikoon
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Seiji Okada
Sopit Wongkham
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 149.0-154.0
17 0 0 0 0 0 17
7. Hypoxia Enhances Aggressiveness of Cholangiocarcinoma Cells Wunchana Seubwai
Ratthaphol Kraiklang
Chaisiri Wongkham
Sopit Wongkham
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 53.0-58.0
15 0 0 0 0 0 15
8. Involvement of p53 and Nuclear Factor-kappaB Signaling Pathway for the Induction of G1-Phase Cell Cycle Arrest of Cholangiocarcinoma Cell Lines by Isomorellin Chariya Hahnvajanawong
Supaluk Ketnimit
Kovit Pattanapanyasat
Natthinee Anantachoke
Banchob Sripa
Khosit Pinmai
Wunchana Seubwai
Vichai Reutrakul
2012 BIOLOGICAL & PHARMACEUTICAL BULLETIN
11.0 (35.0), pp. 1914.0-1925.0
23 0 0 0 0 0 23
9. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Chariya Hahnvajanawong
Jariya Chaiyagool
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Nisana Namwat
Narong Khuntikeo
Banchob Sripa
Ake Pugkhem
Wichittra Tassaneeyakul
2012 WORLD JOURNAL OF GASTROENTEROLOGY
30.0 (18.0), pp. 3955.0-3961.0
20 0 0 0 0 0 20
10. TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro Sonexai Kidoikhammouan
Wunchana Seubwai
Nattawat Tantapotinan
Atit Silsirivanit
Sopit Wongkham
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 155.0-160.0
9 0 0 0 0 0 9
11. Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs Nattapong Puthdee
Kulthida Vaeteewoottacharn
Wunchana Seubwai
Orasa Wonkchalee
Worasak Kaewkong
Amornrat Juasook
Somchai Pinlaor
Chawalit Pairojkul
Chaisiri Wongkham
Seiji Okada
Thidarut Boonmars
Sopit Wongkham
2013 KOREAN JOURNAL OF PARASITOLOGY
6.0 (51.0), pp. 711.0-717.0
4 0 0 0 0 0 4
12. Aberrant Expression of NF-kappa B in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy Wunchana Seubwai
Chaisiri Wongkham
Anucha Puapairoj
Narong Khuntikeo
Ake Pugkhem
Chariya Hahnvajanawong
Jariya Chaiyagool
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2014 PLOS ONE
8.0 (9.0), pp.
35 0 0 0 0 0 35
13. A NOVEL ANTICANCER ALKALOID TILIACORININE INDUCES SUSTAINED ACTIVATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE AND SYNERGIZES WITH CISPLATIN IN CHOLANGIOCARCINOMA CELLS S. Janeklang
W. Seubwai
K. Vaeteewoottacharn
P. Boonsiri
G. Kismali
A. Nakaew
A. Suksamrarn
S. Okada
S. Wongkham
2014 ANTICANCER RESEARCH
10.0 (34.0), pp. 5970.0-5970.0
0 0 0 0 0 0 0
14. Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines Arunee Hematulin
Daniel Sagan
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Sopit Wongkham
2014 INTERNATIONAL JOURNAL OF ONCOLOGY
3.0 (45.0), pp. 1159.0-1166.0
16 0 0 0 0 0 16
15. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
14.0 (15.0), pp. 5873.0-5878.0
37 0 0 0 0 0 37
16. In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma Somkid Janeklang
Archawin Nakaew
Kulthida Vaeteewoottacharn
Wunchana Seubwai
Patcharee Boonsiri
Gorkem Kismali
Apichart Suksamrarn
Seiji Okada
Sopit Wongkham
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
17.0 (15.0), pp. 7473.0-7478.0
1 0 0 0 0 0 1
17. Potential targeted therapy for liver fluke associated cholangiocarcinoma Kulthida Vaeteewoottacharn
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Seiji Okada
Sopit Wongkham
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
6.0 (21.0), pp. 362.0-370.0
11 0 0 0 0 0 11
18. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma Association of diabetes mellitus and cholangiocarcinoma Charupong Saengboonmee
Wunchana Seubwai
Chaisiri Wongkham
Sopit Wongkham
2015 CANCER EPIDEMIOLOGY
3.0 (39.0), pp. 274.0-278.0
16 0 0 0 0 0 16
19. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Wareeporn Wattanawongdon
Chariya Hahnvajanawong
Nisana Namwat
Sirimas Kanchanawat
Thidarut Boonmars
Patcharee Jearanaikoon
Chanwit Leelayuwat
Anchalee Techasen
Wunchana Seubwai
2015 INTERNATIONAL JOURNAL OF ONCOLOGY
1.0 (47.0), pp. 398.0-410.0
34 0 0 0 0 0 34
20. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach Sirorat Pattanapairoj
Atit Silsirivanit
Kanha Muisuk
Wunchana Seubwai
Ubon Cha'on
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Danaipong Chetchotsak
Sopit Wongkham
2015 CLINICAL BIOCHEMISTRY
10-11 (48.0), pp. 668.0-673.0
19 0 0 0 0 0 19
21. Inhibition of NF-kappa B Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells Wunchana Seubwai
Kulthida Vaeteewoottacharn
Ratthaphol Kraiklang
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2015 ONCOLOGY RESEARCH
1-2 (23.0), pp. 21.0-28.0
24 0 0 0 0 0 24
22. Synthesis of 5-fluorouracil nanoparticles and its inhibition of Cholangiocarcinoma in vitro N. Ngernyuang
W. Seubwai
S. Daduang
P. Boonsiri
T. Limpaiboon
J. Daduang
2015 EUROPEAN JOURNAL OF CANCER
(51.0), pp. S135-S135
0 0 0 0 0 0 0
23. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity Kwuntida Uthaisar
Kulthida Vaeteewoottacharn
Wunchana Seubwai
Chutima Talabnin
Kanlayanee Sawanyawisuth
Sumalee Obchoei
Ratthaphol Kraiklang
Seiji Okada
Sopit Wongkham
2016 ONCOLOGY REPORTS
3.0 (36.0), pp. 1435.0-1446.0
20 0 0 0 0 0 20
24. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation Charupong Saengboonmee
Wunchana Seubwai
Chawalit Pairojkul
Sopit Wongkham
2016 SCIENTIFIC REPORTS
(6.0), pp.
39 0 0 0 0 0 39
25. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-kappa B Chatchai Phoomak
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Chaisiri Wongkham
Atit Silsirivanit
Sopit Wongkham
2016 SCIENTIFIC REPORTS
(6.0), pp.
28 0 0 0 0 0 28
26. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent Nipaporn Ngernyuang
Wunchana Seubwai
Sakda Daduang
Patcharee Boonsiri
Temduang Limpaiboon
Jureerut Daduang
2016 MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
(60.0), pp. 411.0-415.0
25 0 0 0 0 0 25
27. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-kappa B and STAT3 Pathways Nattapong Puthdee
Wunchana Seubwai
Kulthida Vaeteewoottacharn
Thidarut Boonmars
Ubon Cha'on
Chatchai Phoomak
Sopit Wongkham
2017 BIOLOGICAL & PHARMACEUTICAL BULLETIN
6.0 (40.0), pp. 751.0-757.0
35 0 0 0 0 0 35
28. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation Chatchai Phoomak
Kulthida Vaeteewoottacharn
Atit Silsirivanit
Charupong Saengboonmee
Wunchana Seubwai
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
Sopit Wongkham
2017 SCIENTIFIC REPORTS
(7.0), pp.
76 0 0 0 0 0 76
29. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-kappa B Charupong Saengboonmee
Wunchana Seubwai
Ubon Cha'on
Kanlayanee Sawanyawisuth
Sopit Wongkham
Chaisiri Wongkham
2017 ANTICANCER RESEARCH
1.0 (37.0), pp. 115.0-123.0
63 0 0 0 0 0 63
30. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis Unchalee Thonsri
Wunchana Seubwai
Sakda Waraasawapati
Kanlayanee Sawanyawisuth
Kulthida Vaeteewoottacharn
Thidarat Boonmars
Ubon Cha'on
2017 HISTOLOGY AND HISTOPATHOLOGY
5.0 (32.0), pp. 503.0-510.0
37 0 0 0 0 0 37
31. Targeting hexokinase II as a possible therapy for cholangiocarcinoma Ubonrat Thamrongwaranggoon
Wunchana Seubwai
Chatchai Phoomak
Sakkarn Sangkhamanon
Ubon Cha'on
Thidarat Boonmars
Sopit Wongkham
2017 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2.0 (484.0), pp. 409.0-415.0
32 0 0 0 0 0 32
32. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process Paweena Dana
Ryusho Kariya
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Kouki Matsuda
Seiji Okada
Sopit Wongkham
2017 ONCOLOGY RESEARCH
7.0 (25.0), pp. 1047.0-1059.0
20 0 0 0 0 0 20
33. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells Waraporn Saentaweesuk
Norie Araki
Kulthida Vaeteewoottacharn
Atit Silsirivanit
Wunchana Seubwai
Chutima Talabnin
Kanha Muisuk
Banchob Sripa
Sopit Wongkham
Seiji Okada
Chaisiri Wongkham
2018 ONCOLOGY RESEARCH
4.0 (26.0), pp. 605.0-616.0
13 0 0 0 0 0 13
34. ANTI-MALARIAL DRUGS ARTESUNATE AND CHLOROQUINE INDUCE CELL DEATH BY DIFFERENT MECHANISMS IN BILE DUCT CANCER CELL LINES Diwakar Guragain
Norie Araki
Atit Silsinivanit
Wunchana Seubwai
Ubon Cha'on
2018 ANTICANCER RESEARCH
3.0 (38.0), pp. 1830.0-1830.0
0 0 0 0 0 0 0
35. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms Diwakar Guragain
Wunchana Seubwai
Daiki Kobayashi
Atit Silsinivanit
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
Sopit Wongkham
Norie Araki
Ubon Cha'on
2018 CELLULAR AND MOLECULAR BIOLOGY
10.0 (64.0), pp. 113.0-118.0
3 0 0 0 0 0 3
36. Chloroquine reduces metastases of cholangiocarcinoma cells in lungs by tail vein assay of cancer metastasis Kanokwan Nahok
Diwakar Guragain
Sopit Wongkham
Wunchana Seubwai
Ubon Cha'on
2018 CANCER SCIENCE
(109.0), pp. 1016.0-1016.0
0 0 0 0 0 0 0
37. Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy Molin Wongwattanakul
Chariya Hahnvajanawong
Wunchana Seubwai
Chanvit Leelayuwat
Temduang Limpaiboon
Patcharee Jearanaikoon
2018 JOURNAL OF MOLECULAR STRUCTURE
(1166.0), pp. 416.0-421.0
5 0 0 0 0 0 5
38. Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma Sonexai Kidoikhammouan
Wunchana Seubwai
Atit Silsirivanit
Sopit Wongkham
Kanlayanee Sawanyawisuth
Chaisiri Wongkham
2019 JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
1.0 (15.0), pp. 148.0-152.0
5 0 0 0 0 0 5
39. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients Atit Silsirivanit
Chatchai Phoomak
Karuntarat Teeravirote
Sasiprapa Wattanavises
Wunchana Seubwai
Charupong Saengboonmee
Zhaoqi Zhan
Jin-ichi Inokuchi
Akemi Suzuki
Sopit Wongkham
2019 GLYCOCONJUGATE JOURNAL
2.0 (36.0), pp. 103.0-111.0
7 0 0 0 0 0 7
40. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma Surangkana Sanmai
Tanakorn Proungvitaya
Temduang Limpaiboon
Daraporn Chua-On
Wunchana Seubwai
Sittiruk Roytrakul
Sopit Wongkham
Chaisiri Wongkham
Ongart Somintara
Sakkarn Sangkhamanon
Siriporn Proungvitaya
2019 ONCOLOGY LETTERS
6.0 (17.0), pp. 5275.0-5282.0
11 0 0 0 0 0 11
41. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines Unchalee Thonsri
Wunchana Seubwai
Sakda Waraasawapati
Sopit Wongkham
Thidarat Boonmars
Ubon Cha'on
Chaisiri Wongkham
2020 ANTICANCER RESEARCH
9.0 (40.0), pp. 5115.0-5124.0
2 0 0 0 0 0 2
42. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient Banchob Sripa
Wunchana Seubwai
Kulthida Vaeteewoottacharn
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Worasak Kaewkong
Kanha Muisuk
Paweena Dana
Chatchai Phoomak
Worachart Lert-itthiporn
Vor Luvira
Chawalit Pairojkul
Bin T. Teh
Sopit Wongkham
Seiji Okada
Yaovalux Chamgramol
2020 HUMAN CELL
3.0 (33.0), pp. 695.0-708.0
31 0 0 0 0 0 31
43. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma Atit Silsirivanit
Atsushi Matsuda
Atsushi Kuno
Chikayuki Tsuruno
Yuta Uenoyama
Wunchana Seubwai
Kiyohiko Angata
Karuntarat Teeravirote
Chaisiri Wongkham
Norie Araki
Youichi Takahama
Sopit Wongkham
Hisashi Narimatsu
2020 CLINICA CHIMICA ACTA
(510.0), pp. 142.0-149.0
3 0 0 0 0 0 3
44. NF-kappa B and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells Charupong Saengboonmee
Chatchai Phoomak
Suangson Supabphol
Kyle R. Covington
Oliver Hampton
Chaisiri Wongkham
Richard A. Gibbs
Kazuo Umezawa
Wunchana Seubwai
Marie-Claude Gingras
Sopit Wongkham
2020 LIFE SCIENCES
(262.0), pp.
1 0 0 0 0 0 1
45. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma Ubonrat Thamrongwaranggoon
Sakkarn Sangkhamanon
Wunchana Seubwai
Paksiree Saranaruk
U. B. O. N. CHA'ON
Sopit Wongkham
2021 IN VIVO
1.0 (35.0), pp. 267.0-274.0
0 0 0 0 0 0 0
46. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication Charupong Saengboonmee
Wunchana Seubwai
Worachart Lert-Itthiporn
Thanachai Sanlung
Sopit Wongkham
2021 CANADIAN JOURNAL OF DIABETES
3.0 (45.0), pp. 282.0-290.0
1 0 0 0 0 0 1
47. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma Prin Sungwan
Worachart Lert-itthiporn
Atit Silsirivanit
Nathakan Klinhom-on
Seiji Okada
Sopit Wongkham
Wunchana Seubwai
2021 PEERJ
(9.0), pp.
0 0 0 0 0 0 0
48. Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus Charupong Saengboonmee
Wunchana Seubwai
Sakkarn Sangkhamanon
Marutpong Detarya
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Sopit Wongkham
2021 CANCER SCIENCE
(112.0), pp. 540.0-540.0
0 0 0 0 0 0 0
49. High glucose: an emerging association between diabetes mellitus and cancer progression Suangson Supabphol
Wunchana Seubwai
Sopit Wongkham
Charupong Saengboonmee
2021 JOURNAL OF MOLECULAR MEDICINE-JMM
(), pp.
0 0 0 0 0 0 0
50. High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 Unchalee Thonsri
Sopit Wongkham
Chaisiri Wongkham
Shinjiro Hino
Mitsuyoshi Nakao
Sittiruk Roytrakul
Tomoaki Koga
Wunchana Seubwai
2021 CANCER SCIENCE
1.0 (112.0), pp. 254.0-264.0
0 0 0 0 0 0 0
51. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Marutpong Detarya
Salak Thaenkaew
Wunchana Seubwai
Somsiri Indramanee
Chatchai Phoomak
Charupong Saengboonmee
Sopit Wongkham
Chaisiri Wongkham
2021 LIFE SCIENCES
(271.0), pp.
0 0 0 0 0 0 0
52. Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis Saeranee Siriphak
Ravinnipa Chanakankun
Tanakorn Proungvitaya
Sittiruk Roytrakul
Doungdean Tummanatsakun
Wunchana Seubwai
Molin Wongwattanakul
Siriporn Proungvitaya
2021 MOLECULES
11.0 (26.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Natural Products for Prevention and Treatment of Cholangiocarcinoma Chariya Hahnvajanawong
Khon Kaen University - Natural Products Chemistry Research Unit
Wunchana Seubwai
Faculty of Medicine - Department of Forensic Medicine
Thidarut Boonmars
Faculty of Medicine - Department of Parasitology
Kulthida Vaeteewoottacharn
Faculty of Medicine - Department of Biochemistry
2012 Srinagarind Medical Journal
(27), pp. 371-380
2. Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters Wunchana Seubwai
Kulthida Vaeteewoottacharn
Kazuo Umezawa
Seiji Okada
Sopit Wongkham
2013 Srinagarind Medical Journal
(28 No 4), pp. 171
3. Determining the Manner of Death Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study Wunchana Seubwai
Wirut Khunkitti
Maneewan Tanratanavijit
Thitichai Wiangsimma
Molin Wongwattanakul
Patcharee Jearanaikoon
Sirinart Srichan
2013 Srinagarind Medical Journal
(28 No 4), pp. 203
4. Application of Molecular Biology Techniques on Forensic Sciences Wunchana Seubwai
Wirut Khunkitti
2014 Srinagarind Medical Journal
(29 No 3), pp. 321-326
5. Potential Glyco-Biomarkers Identified Suicide Victims Wunchana Seubwai
Wirut Khunkitti
Maneewan Tanratanavijit
Thitichai Wiangsimma
Sopit Wongkham
2014 Srinagarind Medical Journal
(29 No 4), pp. 68
6. Diabetogenic Glucose Enhances Aggressive Activities of Cholangiocarcinoma Cell Lines Charupong Saengboonmee
Wunchana Seubwai
Sopit Wongkham
2014 Srinagarind Medical Journal
(29 No 4), pp. 65
7. Tumor Glycolysis as a Target for Cancer Diagnosis and Therapy Wunchana Seubwai 2015 Srinagarind Medical Journal
(30 No 2), pp. 184-192

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ
1. การรักษาแบบมุ่งเป้าสำหรับผู้ป่วยมะเร็งท่อน้ำดี ศ.ดร. โสพิศ วงศ์คำ
นายธนกร ปรุงวิทยา
รศ.ดร. ชัยศิริ วงศ์คำ
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์
ศ.ดร. เต็มดวง ลิ้มไพบูลย์
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
รศ.ดร. ศิริพร ปรุงวิทยา
ผศ.ดร. วันชนะ สืบไวย
ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
2. ตัวยับยั้งวิถี NF-kB เพื่อการรักษามะเร็งท่อน้ำดี รศ.ดร. ชัยศิริ วงศ์คำ
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. วันชนะ สืบไวย
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
3. ตัวยับยั้งวิถีไกลโคไลซิสในกระบวนการก่อและพัฒนามะเร็ง: การประยุกต์ใช้เพื่อการรักษามะเร็งท่อน้ำดี ผศ.ดร. วันชนะ สืบไวย
ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2557 ทุนงบประมาณแผ่นดินประจำปี 2557
4. การวิเคราะห์ลักษณะของเซลล์มะเร็งท่อน้ำดี ที่ดื้อต่อยา gemcitabine และการทำให้เซลล์ที่ดื้อต่อยา gemcitabine กลับไปไวต่อยาโดยใช้ caged xanthones และ rhinacanthin-C ผศ.ดร. ศิริมาศ กาญจนวาศ
นางจริยา หาญวจนวงศ์
ศ.ดร. วิจิตรา ทัศนียกุล
รศ.ดร. นิษณา นามวาท
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร.นพ. สุวิน ว่องวัจนะ
ศ.ดร. วิชัย ริ้วตระกูล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2558 ทุนงบประมาณแผ่นดินประจำปี 2558
5. ผลของ caged xanthone ชนิด forbesione ที่แยกได้จากต้น Garcinia hanburyi ในการยับยั้งมะเร็งท่อน้ำดีและฤทธิ์ความเป็นพิษในหนูแฮมสเตอร์ นางจริยา หาญวจนวงศ์
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ
ผศ.ดร. วันชนะ สืบไวย
ศ.ดร. วิชัย ริ้วตระกูล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2558 ทุนงบประมาณแผ่นดินประจำปี 2558
6. การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
ผศ.ดร. อุบล ชาอ่อน
รศ.ดร. ศิริพร ปรุงวิทยา
ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
7. การใช้กลูโคสและเมตาบอลิซึมของกลูโคส เพื่อเป็นเป้าหมายในการรักษามะเร็งท่อน้ำดี ผศ.ดร. วันชนะ สืบไวย
ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. อุบล ชาอ่อน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
8. การใช้รูปแบบลายพิมพ์อินฟราเรดสเปคตรัมเพื่อเป็นตัวบ่งชี้ชีวภาพรุปแบบใหม่ ในการตรวจวินิจฉัยและติดตามการรักษามะเร็งท่อน้ำดี รศ.ดร. พัชรี เจียรนัยกูร
ผศ.ดร. วันชนะ สืบไวย
นางนิชาดา เจียรนัยกูร
รศ.ดร. ชัยศิริ วงศ์คำ
นายชวลิต ไพโรจน์กุล
นางสาวเยาวลักษณ์ ฉ่ำกระมล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
9. ยาฆ่าพยาธิและยารักษาเบาหวานเพื่อการรักษามะเร็งท่อน้ำดี ผศ.ดร. อุบล ชาอ่อน
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
รศ.ดร. ชัยศิริ วงศ์คำ
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2559 ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2)
10. การใช้รูปแบบลายพิมพ์อินฟราเรดสเปคตรัมเพื่อบ่งชี้แนวใหม่ในการตรวจวินิจฉัยและติดตามการรักษามะเร็งท่อน้ำดี รศ.ดร. พัชรี เจียรนัยกูร
นายชวลิต ไพโรจน์กุล
นางสาวเยาวลักษณ์ ฉ่ำกระมล
รศ.ดร. ชัยศิริ วงศ์คำ
ผศ.ดร. วันชนะ สืบไวย
นางนิชาดา เจียรนัยกูร
โครงการ 2560 ทุนงบประมาณแผ่นดินประจำปี 2560
11. การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดีการค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์
รศ.ดร. ศิริพร ปรุงวิทยา
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์
ผศ.ดร. วันชนะ สืบไวย
นายธนกร ปรุงวิทยา
นางสาวภัทรินทร์ โพธิพันธุ์
ดร. ปวีณา ดานะ
นางสาวปิยะนาฏ บุญเนตร
นางสาววรพร แสนทวีสุข
นางสาวอัญชลี ต้นศรี
นางสาวอุบลรัตน์ ธำรงวรางกูรนายมารุตพงศ์
นางสาวสมสิริ อินทรมณี
ดร. จารุพงษ์ แสงบุญมี
นายฉัตรชัย ภู่มาก
ผศ.ดร. อุบล ชาอ่อน
รศ.ดร. ชัยศิริ วงศ์คำ
ศ.ดร. เต็มดวง ลิ้มไพบูลย์
ชุดโครงการวิจัย 2561 ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม)
12. การใช้กลูโคส และเมตาบอลิซึมของกลูโคส เพื่อเป็นเป้าหมายในการรักษามะเร็งท่อน้ำดี ผศ.ดร. วันชนะ สืบไวย
นางสาวอัญชลี ต้นศรี
นางสาวอุบลรัตน์ ธำรงวรางกูร
ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. อุบล ชาอ่อน
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2561 ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม)
13. การพัฒนาการตรวจวินิจฉัยและการรักษามะเร็งท่อน้ำดีโดยโมเลกุลเป้าหมายแบบองค์รวม รศ.ดร. ศิริพร ปรุงวิทยา
ศ.ดร. โสพิศ วงศ์คำ
รศ.ดร. ชัยศิริ วงศ์คำ
ศ.ดร. เต็มดวง ลิ้มไพบูลย์
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์
ผศ.ดร. อุบล ชาอ่อน
นายธนกร ปรุงวิทยา
ดร. สิทธิรักษ์ รอยตระกูล
ดร. ปวีณา ดานะ
นายฉัตรชัย ภู่มาก
นางสาวภัคสิรี สรณารักษ์
น.ส. เสาวลักษณ์ สายสมบูรณ์
นายจิตรภาณุ มณีสาร
นางสาววรพร แสนทวีสุข
นางสาวศศิประภา วัฒนวิเศษ
นางสาวกรัณฑรัตน์ ธีรวิโรจน์
นางสาวอรสา พนาวัน
ชุดโครงการวิจัย 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)
14. การพัฒนาวิธีวัดระดับบิริรูบินด้วยค่าความเหลืองของส่วนตาขาวในผู้ป่วยมะเร็งท่อน้ำดีโดยแอพพลิเคชั่นบนมือถือ นพ. วร์ ลุวีระ
ศ.ดร. โสพิศ วงศ์คำ
ผศ.ดร. วันชนะ สืบไวย
ดร. จารุพงษ์ แสงบุญมี
โครงการ 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)
15. ชุดตรวจตัวบ่งชี้ชีวภาพในเลือดแบบองค์รวมเพื่อวินิจฉัยและพยากรณ์โรค มะเร็งท่อน้ำดี ศ.ดร. โสพิศ วงศ์คำ
รศ.ดร. ชัยศิริ วงศ์คำ
รศ.ดร. ศิริพร ปรุงวิทยา
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์
นายธนกร ปรุงวิทยา
นางสาวศศิประภา วัฒนวิเศษ
นางสาวกรัณฑรัตน์ ธีรวิโรจน์
โครงการ 2562 ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม)

0.07406473159790039